Quantcast

Latest Clinical trial Stories

2014-10-02 12:31:07

Additional $12.5 Million in Matching Gifts Bring Total Commitment to $34.2 million WASHINGTON, Oct. 2, 2014 /PRNewswire-USNewswire/ -- After the generous outpouring of support from people all around the globe due to this summer's Ice Bucket Challenge, the Board of Trustees of The ALS Association has approved an initial expenditure of $21.7 million in funding to support six programs and initiatives to expedite the search for treatments and a cure for amyotrophic lateral sclerosis...

2014-10-02 08:30:08

CSSi, the leader in clinical research patient recruitment solutions, will be a featured participant and sponsor at Arena's Outsourcing in Clinical Trials New England Conference and the SCRS Site Solutions Summit. GLEN BURNIE, Md., Oct. 2, 2014 /PRNewswire/ -- CSSi (www.CSSiEnroll.com), the leader in patient recruitment solutions for the clinical research industry, is pleased to announce its participation in two upcoming industry conferences during the month of October. President...

2014-10-02 08:29:17

SAN DIEGO, Oct. 2, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), a clinical-stage biopharmaceutical company, announced today that Edwin L. Parsley, D.O. has joined the Company as its Chief Medical Officer and Senior Vice President. Dr. Parsley has been actively engaged with the Company since it acquired Aires Pharmaceuticals, Inc. in February 2014. He has served as Mast's interim Chief Medical Officer since September 2014 and as Chief Medical Officer of Aires since...

2014-10-02 08:24:49

LUGANO, Switzerland, October 2, 2014 /PRNewswire/ -- Rare cancer patients need access to innovative cancer drugs A consensus paper published in the Annals of Oncology today by Rare Cancers Europe (RCE) calls for new methodologies to be applied to clinical studies in rare cancers. RCE - a multi-stakeholder initiative representing patient associations, medical societies and industry - is calling both the community of researchers and European authorities to address...

2014-10-02 00:21:35

-FREEDOM-1 study showed that ITCA 650 demonstrated positive results when added to standard oral diabetes medications. All endpoints were met regarding HbA1c and weight reductions, as well as the percent of patients treated to goal. Pre-specified sub-group analyses on HbA1c reductions over time also showed clinically and statistically significant impact across a wide spectrum of patients and background medications. Significant HbA1c reductions were observed over the 39 weeks ranging from a...

2014-10-01 23:08:17

Clinical Conductor CTMS and OpenClinica officially announce a newly formed strategic partnership, and beginning immediately, Clinical Conductor CTMS will begin including OpenClinica Enterprise EDC as part of its product offerings. Rochester, NY (PRWEB) October 01, 2014 Clinical Conductor CTMS, the leading clinical trial management system, and OpenClinica, one of the world's most widely adopted electronic data capture (EDC) software platforms, are pleased to announce the formation of a...

2014-10-01 23:08:10

We’re pleased to announce that RPM Alliance is our newest partner San Francisco, CA (PRWEB) October 01, 2014 Medrio, a leading provider of eClinical Software as a Service (SaaS) for clinical research, announced today that RPM Alliance, providers of clinical research and data management services to biotech and pharmaceutical companies, have joined Medrio’s Partner Program. “We are delighted to add RPM Alliance to our Partner Program,” says Scott Weidley, VP of Sales and Marketing...

2014-10-01 16:26:43

Global Clinical Trials Get Breakthrough Technology to Improve Signal Detection HAMILTON, N.J., Oct. 1, 2014 /PRNewswire/ -- MedAvante, Inc., the world's leading provider of technology-enabled signal detection solutions in clinical trials of treatments for central nervous system (CNS) disorders, announced the deployment of its groundbreaking Virgil Investigative Study Platform in multiple clinical trials worldwide. The Virgil platform, developed specifically for investigative sites,...

2014-10-01 12:31:51

--- CCPME is a fund jointly set up by the Caisse de dépôt et placement du Québec ("CDPQ") and by Capital régional et coopératif Desjardins ("CRCD") --- MONTREAL, Oct. 1(st) 2014 /CNW Telbec/ - JSS Medical Research Inc., a Montreal based Contract Research Organization (CRO), conducting Phase I - IV Clinical Trials, Post Marketing Observational Studies as well as Epidemiological and Health Economics Research for Pharmaceutical, Biotechnology and Device companies, announced today...

2014-10-01 12:31:29

SAN FRANCISCO, Oct 1, 2014 /PRNewswire/ -- In the world of mobile technology we have an app for everything, but mission-critical information about the clinical trials that physicians are managing seems to be in the prehistoric days. Clinical trials have inherently become more complex over the years, especially with infectious disease, cardiovascular, oncology and CNS trials. The number of vendors and pharmaceutical company contacts have soared - the average study has 30+ contacts...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin